GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Life Technologies Corp (FRA:IVN) » Definitions » Cash Flow from Investing

Life Technologies (FRA:IVN) Cash Flow from Investing : €-192 Mil (TTM As of Sep. 2013)


View and export this data going back to . Start your Free Trial

What is Life Technologies Cash Flow from Investing?

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

For the three months ended in Sep. 2013, Life Technologies spent €21 Mil on purchasing property, plant, equipment. It gained €0 Mil from selling property, plant, and equipment. It spent €-0 Mil on purchasing business. It gained €0 Mil from selling business. It spent €1 Mil on purchasing investments. It gained €0 Mil from selling investments. It paid €0Mil for net Intangibles purchase and sale. And it received €0 Mil from other investing activities. In all, Life Technologies spent €22 Mil on investment activities in financial market and operating subsidiaries for the three months ended in Sep. 2013.


Life Technologies Cash Flow from Investing Historical Data

The historical data trend for Life Technologies's Cash Flow from Investing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Life Technologies Cash Flow from Investing Chart

Life Technologies Annual Data
Trend Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Cash Flow from Investing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,138.39 -176.99 -90.57 -115.43 -212.96

Life Technologies Quarterly Data
Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13
Cash Flow from Investing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -23.74 -105.94 -23.46 -40.60 -22.03

Life Technologies Cash Flow from Investing Calculation

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

If a company spends cash on property, plant and equipment (PPE), this will reduce their cash position. This is called Capital Expenditures (CPEX).

Likewise, if a company buys another company for cash, this will reduce their cash position.

Life Technologies's Cash Flow from Investing for the fiscal year that ended in Dec. 2012 is calculated as:

Life Technologies's Cash Flow from Investing for the quarter that ended in Sep. 2013 is calculated as:


Cash Flow from Investing for the trailing twelve months (TTM) ended in Sep. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was €-192 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Life Technologies  (FRA:IVN) Cash Flow from Investing Explanation

Cash flow from investing contains nine items:

1. Purchase Of Property, Plant, Equipment:
Purchase of PPE indicates the amount used to purchase property, plant, and equipment.

Life Technologies's purchase of property, plant, equipment for the three months ended in Sep. 2013 was €-21 Mil. It means Life Technologies spent €21 Mil on purchasing property, plant, equipment.

In the capital spending for property, plant and equipment (PPE), some part of spending may be from the expansion of business. The business needs more property, plant and equipment (PPE) as it grows. Another part may be from replacement of the property, plant and equipment (PPE) of existing business. For some companies, the cash spent on replacing of the property, plant and equipment (PPE) of the existing business will be close to the depreciation of property, plant and equipment (PPE) reported in the income statement.

In Warren Buffett's definition of Owner's Earnings, he deducts the estimate of the cost of replacing the property, plant and equipment (PPE) of the existing business from cash flow from operations. The cash spent on the new property, plant, and equipment is not deducted. The reason is because these are not costs of the existing business. In his 1986 letter to shareholders, Warren Buffett wrote this about owner earnings:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume....Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

2. Sale Of Property, Plant, Equipment:
Sale of PPE indicates the amount gained from selling property, plant, and equipment.

Life Technologies's sale of property, plant, equipment for the three months ended in Sep. 2013 was €0 Mil. It means Life Technologies gained €0 Mil from selling property, plant, and equipment.

3.Purchase Of Business:
Purchase of business indicates the amount used to purchase business.

Life Technologies's purchase of business for the three months ended in Sep. 2013 was €0 Mil. It means Life Technologies spent €-0 Mil on purchasing business.

4. Sale Of Business:
Sale of business indicates the amount gained from selling business.

Life Technologies's sale of business for the three months ended in Sep. 2013 was €0 Mil. It means Life Technologies gained €0 Mil from selling business.

5. Purchase Of Investment:
Purchase of Investments represents cash outflow on the purchase of investments in securities.

Life Technologies's purchase of investment for the three months ended in Sep. 2013 was €-1 Mil. It means Life Technologies spent {stock_data.stock.currency_symbol}}1 Mil on purchasing investments.

6. Sale Of Investment:
Sale of Investments represents cash inflow on the sale of investments in securities.

Life Technologies's sale of investment for the three months ended in Sep. 2013 was €0 Mil. It means Life Technologies gained €0 Mil from selling investments.

7. Net Intangibles Purchase And Sale:
Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

Life Technologies's net Intangibles purchase and sale for the three months ended in Sep. 2013 was €0 Mil. It means Life Technologies paid €0 Mil for net Intangibles purchase and sale.

8. Cash From Discontinued Investing Activities:
Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Life Technologies's cash from discontinued investing activities for the three months ended in Sep. 2013 was 0 Mil. It means Life Technologies paid €0 Mil for discontinued investing activities.

9. Cash From Other Investing Activities:
Cash from other investing activities means the cash received by a company that comes from other investing activities.

Life Technologies's cash from other investing activities for the three months ended in Sep. 2013 was €0 Mil. It means Life Technologies received €0 Mil from other investing activities.


Life Technologies Cash Flow from Investing Related Terms

Thank you for viewing the detailed overview of Life Technologies's Cash Flow from Investing provided by GuruFocus.com. Please click on the following links to see related term pages.


Life Technologies (FRA:IVN) Business Description

Traded in Other Exchanges
N/A
Address
Life Technologies Corp began operations as a California partnership in 1987 and incorporated in California in 1989. In 1997, the Company reincorporated as a Delaware corporation. On November 21, 2008, Invitrogen Corporation, a predecessor company to Life Technologies, completed the acquisition of Applied Biosystems, Inc. to form a new company called Life Technologies Corporation. The Company is a global life sciences company dedicated to improving the human condition. The Company's systems, consumables and services enable researchers and commercial markets to accelerate scientific exploration, to discoveries and developments that better the quality of life. The Company's products are also used in forensics, food and water testing and other industrial applications. The Company delivers a range of products and services, including systems, instruments, reagents, software, and custom services. Its growing portfolio of products includes innovative technologies for capillary electrophoresis-based sequencing, next generation sequencing, PCR, sample preparation, cell culture, RNA interference analysis, functional genomics research, proteomics and cell biology applications, as well as clinical diagnostic applications, forensics and animal, food, pharmaceutical and water testing analysis. The Company also provides its customers convenient and value-added purchasing options through thousands of sales and service professionals, e-commerce capabilities and onsite supply center solutions. The Company operates is business under three divisions: Molecular Biology Systems ('MBS'), Cell Systems ('CS'), and Genetic Systems ('GS'). The MBS division includes the molecular biology-based technologies, including basic and real-time PCR, RNAi, DNA synthesis, sample prep, transfection, cloning and protein expression profiling, protein analysis and thermo-cycler instrumentation. The CS division includes all product lines used in the study of cell function, including cell culture media and sera, stem cells and related tools, cellular imaging products, antibodies, drug discovery services and cell therapy related products. The GS division includes capillary electrophoresis systems and reagents and next generation sequencing systems and reagents, including the SOLiDTM and Ion TorrentTM systems, as well as reagent kits developed specifically for applied markets, such as forensics and food safety, animal health and pharmaceutical quality monitoring. The Company offers many different products and services and is continually developing and/or acquiring others. Some of its specific product categories include the following: 'High-throughput' gene cloning and expression technology; Pre-cast electrophoresis products; Antibodies; Magnetic beads; Molecular Probes fluorescence-based technologies; Transfection reagents; PCR and Real Time PCR systems and reagents; and RNA Interference reagents. The Company's manufacturing operations require a variety of raw materials, elec

Life Technologies (FRA:IVN) Headlines

No Headlines